Dominic Rowe


  • 2764 Citations
  • 26 h-Index
1986 …2023
If you made any changes in Pure these will be visible here soon.

Personal profile


Professor Rowe is the Foundation Professor of Neurology in the Faculty of Medicine and Health Sciences at Macquarie University; Chairman of Macquarie Neurology, and Consultant Neurologist at Macquarie University Hospital.

For ten years he was Chairman of the MND Research Institute of Australia, taking this funding body from minor influence to the major source of funding for MND research in Australia. He is the Principal Investigator on the Parkinson’s Progression Marker Initiative, re-sponsible for the only Australian site in this ground breaking collabo-rative research in PD. Together with Professor Kiernan and others, he founded the Australian Motor Neurone Disease Registry. For the last nine years he has been instrumental in the set up and im-plementation of the Faculty of Medicine and Health Sciences at Macquarie University.

Professor Rowe was awarded a Member of the Order of Australia in the 2012 Queen’s Birthday Honour List for services to Medicine and Neurology, particularly Motor Neurone Disease and Parkinson’s.

Professor Rowe is a member of the Australian and New Zealand Associ-ation of Neurologists; International Movement Disorder Society and a Fellow of the Royal Australasian College of Physicians.
He is a Chairman of Neurology at Macquarie University Hospital and the founder of Macquarie Neurolo-gy; an adult neurology practice that performs more than 10,000 patient episodes per year. Macquarie Neu-rology manages the care of more than 200 patients with MND, 600 patients with Parkinson’s and 100 patients with Multiple Sclerosis.

Fingerprint Dive into the research topics where Dominic Rowe is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles
Parkinson Disease Medicine & Life Sciences
Amyotrophic Lateral Sclerosis Medicine & Life Sciences
Mutation Medicine & Life Sciences
Motor Neuron Disease Medicine & Life Sciences
alpha-Synuclein Medicine & Life Sciences
Genes Medicine & Life Sciences
Age of Onset Medicine & Life Sciences
Phosphotransferases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2009 2023

NHMRC - PARTNERSHIP PROJECTS 2017: Motor Neurone Disease: Patient centred care for a progressive neurological disease— evidence driving policy.

Kiernan, M. C., Wray, N. R., Talman, P., Vucic, S., Mathers, S., Henderson, R. D., Bellgard, M., Aoun, S. M., Savulescu, J., Rowe, D., Birks, C., Blair, I., Hansen, C., Hogden, A., Needham, M., Olds, P., Schultz, D., Soulis, T., Williams, S., Zoing, M. & Smith, G.


Project: Research

Non-Alzheimer's disease degenerative dementias: Identifying prodromal genetic/familial phenotypes, modifying factors, and protein variations involved in progression

Rowe, D., Halliday, G., Hodges, J., Lewis, S., Piguet, O., Kril, J. J., Kwok, J., Villemagne, V., Kiernan, M. & McKeith, I.


Project: Research

Seeking genomic factors that modify the progression of MND

Williams, K., Blair, I., Bauer, D. C., Twine, N., Nicholson, G. & Rowe, D.


Project: Research

Research Outputs 1986 2020

Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study

Simuni, T., Uribe, L., Cho, H. R., Caspell-Garcia, C., Coffey, C. S., Siderowf, A., Trojanowski, J. Q., Shaw, L. M., Seibyl, J., Singleton, A., Toga, A. W., Galasko, D., Foroud, T., Tosun, D., Poston, K., Weintraub, D., Mollenhauer, B., Tanner, C. M., Kieburtz, K., Chahine, L. M. & 5 othersReimer, A., Hutten, S. J., Bressman, S., Marek, K. & PPMI Investigators, 1 Jan 2020, In : The Lancet Neurology. 19, 1, p. 71-80 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Dopamine Plasma Membrane Transport Proteins
Parkinson Disease
Cross-Sectional Studies
Corpus Striatum

Diffusion kurtosis and quantitative susceptibility mapping MRI are sensitive to structural abnormalities in amyotrophic lateral sclerosis

Welton, T., Maller, J. J., Lebel, R. M., Tan, E. T., Rowe, D. B. & Grieve, S. M., 22 Jul 2019, In : NeuroImage: Clinical. 24, p. 1-8 8 p., 101953.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Amyotrophic Lateral Sclerosis
Motor Cortex
Linear Models

Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)

Prakash, N., Caspell-Garcia, C., Coffey, C., Siderowf, A., Tanner, C. M., Kieburtz, K., Mollenhauer, B., Galasko, D., Merchant, K., Foroud, T., Chahine, L. M., Weintraub, D., Casaceli, C., Dorsey, R., Wilson, R., Herzog, M., Daegele, N., Arnedo, V., Frasier, M., Sherer, T. & 5 othersMarek, K., Frank, S., Jennings, D., Simuni, T. & Parkinson's Progression Markers Initiative, May 2019, In : Parkinsonism and Related Disorders. 62, p. 201-209 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Spinal Puncture
Parkinson Disease

Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice

McCann, E. P., Fifita, J. A., Grima, N., Galper, J., Mehta, P., Freckleton, S. E., Zhang, K. Y., Henden, L., Hogan, A. L., Chan Moi Fat, S., Wu, S. S. L., Jagaraj, C. J., Berning, B. A., Williams, K. L., Twine, N. A., Bauer, D., Piguet, O., Hodges, J., Kwok, J. B. J., Halliday, G. M. & 7 othersKiernan, M. C., Atkin, J., Rowe, D. B., Nicholson, G. A., Walker, A. K., Blair, I. P. & Yang, S., 5 Nov 2019, In : Journal of Neurology, Neurosurgery and Psychiatry.

Research output: Contribution to journalArticleResearchpeer-review

DNA-Binding Proteins
Transgenic Mice
Spinal Cord

Genetic testing for familial amyotrophic lateral sclerosis (ALS): insights and challenges

Crook, A., Hogden, A., Mumford, V., Blair, I. P., Williams, K. L. & Rowe, D. B., 1 Nov 2019, In : Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 20, Supplement 1, p. 327 1 p., CMS-01.

Research output: Contribution to journalMeeting abstractResearchpeer-review

Genetic Testing
Amyotrophic Lateral Sclerosis
Decision Making
Genetic Counseling